Fig. 2From: Cardiovascular risk in patients with alpha-1-antitrypsin deficiencyFrequency of self-reported pulmonary comorbidities in patients with COPD, AATD + T and AATD-T (OR (CI95%) p-value, compared AATD + T vs. COPD); TH = augmentation therapyBack to article page